Cluster composition

Functions

Category	Name	IntersectionWithQuery	PValue	GenesInTerm	GenesInQuery	GenesInTermInQuery	ID
GeneOntologyMolecularFunction	protein serine kinase activity	TRIO CDK11A MAP3K1 TTBK1 RPS6KA4 CAMKK1 MAP3K14 STK32C TESK1 HASPIN MAPK4 MAP3K21 MAP2K1 CDK4	5.28e-06	363	179	14	GO:0106310
GeneOntologyMolecularFunction	protein serine/threonine kinase activity	TRIO CDK11A MAP3K1 TTBK1 RPS6KA4 CAMKK1 MAP3K14 STK32C TESK1 HASPIN MAPK4 MAP3K21 MAP2K1 CDK4	5.20e-05	446	179	14	GO:0004674
GeneOntologyMolecularFunction	adrenergic receptor activity	ADRA1B ADRA2A ADRB1	8.12e-05	10	179	3	GO:0004935
GeneOntologyMolecularFunction	protein kinase activity	ERBB2 TRIO CDK11A MAP3K1 TTBK1 RPS6KA4 CAMKK1 WEE1 MAP3K14 STK32C TESK1 HASPIN MAPK4 MAP3K21 MAP2K1 CDK4	1.04e-04	600	179	16	GO:0004672
GeneOntologyMolecularFunction	low voltage-gated calcium channel activity	CACNA1I CACNA1H	2.38e-04	3	179	2	GO:0008332
GeneOntologyMolecularFunction	TRAIL receptor activity	TNFRSF10B TNFRSF10A	4.74e-04	4	179	2	GO:0036463
GeneOntologyMolecularFunction	G protein-coupled amine receptor activity	ZNF219 ADRA1B ADRA2A ADRB1	4.88e-04	41	179	4	GO:0008227
GeneOntologyMolecularFunction	phosphotransferase activity, alcohol group as acceptor	ERBB2 TRIO CDK11A MAP3K1 TTBK1 RPS6KA4 CAMKK1 WEE1 MAP3K14 STK32C TESK1 HASPIN MAPK4 MAP3K21 MAP2K1 CDK4	6.68e-04	709	179	16	GO:0016773
GeneOntologyMolecularFunction	TRAIL binding	TNFRSF10B TNFRSF10A	7.85e-04	5	179	2	GO:0045569
Domain	Prot_kinase_dom	ERBB2 TRIO CDK11A MAP3K1 TTBK1 MARVELD3 RPS6KA4 CAMKK1 WEE1 MAP3K14 STK32C TESK1 HASPIN MAPK4 MAP3K21 MAP2K1 CDK4	3.14e-06	489	173	17	IPR000719
Domain	PROTEIN_KINASE_ATP	ERBB2 TRIO CDK11A MAP3K1 TTBK1 RPS6KA4 CAMKK1 WEE1 MAP3K14 STK32C TESK1 HASPIN MAPK4 MAP3K21 MAP2K1 CDK4	5.99e-06	459	173	16	PS00107
Domain	Ser/Thr_kinase_AS	TRIO CDK11A MAP3K1 TTBK1 RPS6KA4 CAMKK1 WEE1 MAP3K14 STK32C HASPIN MAPK4 MAP3K21 MAP2K1 CDK4	6.24e-06	357	173	14	IPR008271
Domain	S_TKc	TRIO CDK11A MAP3K1 TTBK1 RPS6KA4 CAMKK1 WEE1 MAP3K14 STK32C HASPIN MAPK4 MAP3K21 MAP2K1 CDK4	6.65e-06	359	173	14	SM00220
Domain	PROTEIN_KINASE_ST	TRIO CDK11A MAP3K1 TTBK1 RPS6KA4 CAMKK1 WEE1 MAP3K14 STK32C HASPIN MAPK4 MAP3K21 MAP2K1 CDK4	7.31e-06	362	173	14	PS00108
Domain	Protein_kinase_ATP_BS	ERBB2 MAP3K1 TTBK1 RPS6KA4 CAMKK1 WEE1 MAP3K14 STK32C TESK1 HASPIN MAPK4 MAP3K21 MAP2K1 CDK4	1.23e-05	379	173	14	IPR017441
Domain	Pkinase	TRIO CDK11A MAP3K1 TTBK1 RPS6KA4 CAMKK1 WEE1 MAP3K14 STK32C TESK1 HASPIN MAPK4 MAP2K1 CDK4	1.30e-05	381	173	14	PF00069
Domain	PROTEIN_KINASE_DOM	ERBB2 TRIO CDK11A MAP3K1 TTBK1 RPS6KA4 CAMKK1 WEE1 MAP3K14 STK32C TESK1 HASPIN MAPK4 MAP3K21 MAP2K1 CDK4	1.46e-05	493	173	16	PS50011
Domain	RBM1CTR	RBMXL1 RBMXL2 RBMX	4.23e-05	8	173	3	PF08081
Domain	RBM1CTR	RBMXL1 RBMXL2 RBMX	4.23e-05	8	173	3	IPR012604
Domain	Kinase-like_dom	ERBB2 TRIO CDK11A MAP3K1 TTBK1 RPS6KA4 CAMKK1 WEE1 MAP3K14 STK32C TESK1 HASPIN MAPK4 MAP3K21 MAP2K1 CDK4	4.59e-05	542	173	16	IPR011009
Domain	ADR_fam	ADRA1B ADRA2A ADRB1	8.94e-05	10	173	3	IPR002233
Domain	VDCC_T_a1	CACNA1I CACNA1H	2.54e-04	3	173	2	IPR005445
Domain	TNFR_10	TNFRSF10B TNFRSF10A	5.06e-04	4	173	2	IPR020465
Pathway	REACTOME_ADRENOCEPTORS	ADRA1B ADRA2A ADRB1	3.65e-05	9	109	3	M27302
Pathway	REACTOME_ADRENOCEPTORS	ADRA1B ADRA2A ADRB1	3.65e-05	9	109	3	MM15009
Pathway	REACTOME_SEMA4D_INDUCED_CELL_MIGRATION_AND_GROWTH_CONE_COLLAPSE	ERBB2 ARHGEF11 PLXNB1	7.09e-05	11	109	3	MM15046
Pubmed	A dual-activity topoisomerase complex regulates mRNA translation and turnover.	ERBB2 SETD1B KMT2B MORN1 TRIO TOR4A ARHGEF11 REPIN1 REXO1 PRR12 TNRC18 MGAT1 HEG1 KCNH2 CASKIN1 TP53I13 CACNA1H MARVELD3 SEMA7A SZT2 FBRSL1 SMG5 GRIN2D STK32C TESK1 GAS2L1 SCAP DNAJC14 KANK3 LRP3 MAPKBP1 CABIN1 CEP170B	3.50e-15	1105	194	33	35748872
Pubmed	A central chaperone-like role for 14-3-3 proteins in human cells.	ERBB2 TRIO NUMBL MTCL1 ZNF598 KIF13B RBM15 CAMKK1 WEE1 MAP3K14 LARP1 FAM117B STK32C PTPN21 TESK1 LSR MAP7D1 MEPCE PROSER2 USP54 MAPK4 MAP3K21 MAP2K1 CEP170B	1.14e-10	861	194	24	36931259
Pubmed	Variability within alpha- and beta-adrenoreceptor genes as a predictor of cardiovascular function at rest and in response to mental challenge.	ADRA1B ADRA2A ADRB1	6.81e-07	4	194	3	12023679
Pubmed	Expression of the Bcl-2 protein BAD promotes prostate cancer growth.	TNFRSF10B TNFRSF10A MAP3K1 MAP3K14 TNFRSF8	1.25e-06	34	194	5	19593445
Pubmed	Chromosomal organization of adrenergic receptor genes.	ADRA1B ADRA2A ADRB1	1.69e-06	5	194	3	2154750
Pubmed	Paralog knockout profiling identifies DUSP4 and DUSP6 as a digenic dependence in MAPK pathway-driven cancers.	ERBB2 SETD1B KMT2B APC2 CDK11A MCL1 BCL2L12 TTBK1 KCNH2 CABP1 RPS6KA4 TOR2A MAPK4 MAP2K1 BBC3 CDK4	3.87e-06	730	194	16	34857952
Pubmed	Genomic organization of adrenergic and serotonin receptors in the mouse: linkage mapping of sequence-related genes provides a method for examining mammalian chromosome evolution.	ERBB2 ADRA1B ADRA2A ADRB1	5.22e-06	21	194	4	1676978
Pubmed	Transformation by oncogenic RAS sensitizes human colon cells to TRAIL-induced apoptosis by up-regulating death receptor 4 and death receptor 5 through a MEK-dependent pathway.	TNFRSF10B TNFRSF10A MAP2K1	5.88e-06	7	194	3	15757891
Pubmed	Spatiotemporal profile of postsynaptic interactomes integrates components of complex brain disorders.	ZNF219 TRIO NUMBL APC2 ARHGEF11 MAGI2 CASKIN1 MTCL1 PRRC2A KIF13B PRR36 ARHGAP39 GRIN2D TXLNA MAP7D1 TNKS CABIN1 CEP170B	8.53e-06	963	194	18	28671696
Pubmed	Quantitative analysis of HSP90-client interactions reveals principles of substrate recognition.	ERBB2 CDK11A LARP4B CAMKK1 MAP3K14 STK32C TESK1 HASPIN MAPK4 FBXO27 CDK4	8.71e-06	372	194	11	22939624
Pubmed	Cardiac function in genetically engineered mice with altered adrenergic receptor signaling.	ADRA1B ADRA2A ADRB1	9.38e-06	8	194	3	9139936
Pubmed	Adrenergic regulation of AMP-activated protein kinase in brown adipose tissue in vivo.	ADRA1B ADRA2A ADRB1	1.40e-05	9	194	3	21209093
Pubmed	Polymorphism in tumor necrosis factor-related apoptosis-inducing ligand receptor 1 is associated with poor viral response to interferon-based hepatitis C virus therapy in HIV/hepatitis C virus-coinfected individuals.	MCL1 TNFRSF10B TNFRSF10A	1.99e-05	10	194	3	20802294
Pubmed	Tat-induced FOXO3a is a key mediator of apoptosis in HIV-1-infected human CD4+ T lymphocytes.	TNFRSF10B TNFRSF10A BBC3	2.73e-05	11	194	3	19050264
Pubmed	Qualitative and quantitative analyses of protein phosphorylation in naive and stimulated mouse synaptosomal preparations.	NUMBL MAGI2 CASKIN1 PRRC2A CAMKK1 MYO18A ARHGAP39 PLEKHA6 C1orf198 CEP170B	2.79e-05	347	194	10	17114649
Pubmed	Modeling ductal carcinoma in situ: a HER2-Notch3 collaboration enables luminal filling.	ERBB2 NOTCH3	3.10e-05	2	194	2	21743488
Pubmed	Expression of TNF-related apoptosis-inducing ligand (TRAIL) and its receptors in gastric carcinoma and tumor-infiltrating lymphocytes: a possible mechanism of immune evasion of the tumor.	TNFRSF10B TNFRSF10A	3.10e-05	2	194	2	11862476
Pubmed	Association of 14-3-3 proteins to beta1-adrenergic receptors modulates Kv11.1 K+ channel activity in recombinant systems.	ADRB1 KCNH2	3.10e-05	2	194	2	16914520
Pubmed	A T-type calcium channel required for normal function of a mammalian mechanoreceptor.	CACNA1I CACNA1H	3.10e-05	2	194	2	12808460
Pubmed	Hypoxia/reoxygenation up-regulates death receptor expression and enhances apoptosis in human biliary epithelial cells.	TNFRSF10B TNFRSF10A	3.10e-05	2	194	2	19643115
Pubmed	TRAIL-induced apoptosis and expression of death receptor TRAIL-R1 and TRAIL-R2 in bladder cancer cells.	TNFRSF10B TNFRSF10A	3.10e-05	2	194	2	20430723
Pubmed	Rebound burst firing in the reticular thalamus is not essential for pharmacological absence seizures in mice.	CACNA1I CACNA1H	3.10e-05	2	194	2	25071191
Pubmed	Whole Exome Sequencing of Hemiplegic Migraine Patients Shows an Increased Burden of Missense Variants in CACNA1H and CACNA1I Genes.	CACNA1I CACNA1H	3.10e-05	2	194	2	36786913
Pubmed	Tankyrase 1 interacts with Mcl-1 proteins and inhibits their regulation of apoptosis.	MCL1 TNKS	3.10e-05	2	194	2	12475993
Pubmed	Modulation of TRAIL resistance in colon carcinoma cells: different contributions of DR4 and DR5.	TNFRSF10B TNFRSF10A	3.10e-05	2	194	2	21272366
Pubmed	Epigenetic Modification of Death Receptor Genes for TRAIL and TRAIL Resistance in Childhood B-Cell Precursor Acute Lymphoblastic Leukemia.	TNFRSF10B TNFRSF10A	3.10e-05	2	194	2	34198757
Pubmed	Human cytomegalovirus glycoprotein UL141 targets the TRAIL death receptors to thwart host innate antiviral defenses.	TNFRSF10B TNFRSF10A	3.10e-05	2	194	2	23498957
Pubmed	TRAIL and immunity: more than a license to kill tumor cells.	TNFRSF10B TNFRSF10A	3.10e-05	2	194	2	15608691
Pubmed	Expression of tumor necrosis factor--related apoptosis-inducing ligand receptors 1 and 2 in melanoma.	TNFRSF10B TNFRSF10A	3.10e-05	2	194	2	16778114
Pubmed	Puma(*)Mcl-1 interaction is not sufficient to prevent rapid degradation of Mcl-1.	MCL1 BBC3	3.10e-05	2	194	2	16007132
Pubmed	8p21.3 deletion suggesting a probable role of TRAIL-R1 and TRAIL-R2 as candidate tumor suppressor genes in the pathogenesis of multiple myeloma.	TNFRSF10B TNFRSF10A	3.10e-05	2	194	2	23423784
Pubmed	Differential regulation of the TRAIL death receptors DR4 and DR5 by the signal recognition particle.	TNFRSF10B TNFRSF10A	3.10e-05	2	194	2	15356269
Pubmed	Loss of TRAIL-receptors is a recurrent feature in pancreatic cancer and determines the prognosis of patients with no nodal metastasis after surgery.	TNFRSF10B TNFRSF10A	3.10e-05	2	194	2	23460812
Pubmed	Increased expression of CD30 and CD57 molecules on CD4(+) T cells from children with atopic asthma: a preliminary report.	TNFRSF8 B3GAT1	3.10e-05	2	194	2	18201430
Pubmed	Protein products of human Gas2-related genes on chromosomes 17 and 22 (hGAR17 and hGAR22) associate with both microfilaments and microtubules.	GAS2L1 GAS2L2	3.10e-05	2	194	2	12584248
Pubmed	Human normal hepatocytes are susceptible to apoptosis signal mediated by both TRAIL-R1 and TRAIL-R2.	TNFRSF10B TNFRSF10A	3.10e-05	2	194	2	14576771
Pubmed	CD95 and TRAIL receptor-mediated activation of protein kinase C and NF-kappaB contributes to apoptosis resistance in ductal pancreatic adenocarcinoma cells.	TNFRSF10B TNFRSF10A	3.10e-05	2	194	2	11464292
Pubmed	Human embryonic and induced pluripotent stem cells express TRAIL receptors and can be sensitized to TRAIL-induced apoptosis.	TNFRSF10B TNFRSF10A	3.10e-05	2	194	2	23806100
Pubmed	Expression quantitative trait loci for TNFRSF10 influence both HBV infection and hepatocellular carcinoma development.	TNFRSF10B TNFRSF10A	3.10e-05	2	194	2	26297860
Pubmed	TRAIL-receptor preferences in pancreatic cancer cells revisited: Both TRAIL-R1 and TRAIL-R2 have a licence to kill.	TNFRSF10B TNFRSF10A	3.10e-05	2	194	2	26138346
Pubmed	Targeting transcription of MCL-1 sensitizes HER2-amplified breast cancers to HER2 inhibitors.	ERBB2 MCL1	3.10e-05	2	194	2	33589591
Pubmed	NOTCH3 signaling pathway plays crucial roles in the proliferation of ErbB2-negative human breast cancer cells.	ERBB2 NOTCH3	3.10e-05	2	194	2	18339869
Pubmed	Prediction of proapoptotic anticancer therapeutic response in vivo based on cell death visualization and TRAIL death ligand-receptor interaction.	TNFRSF10B TNFRSF10A	3.10e-05	2	194	2	21785270
Pubmed	The role of TRAIL death receptors in the treatment of hematological malignancies.	TNFRSF10B TNFRSF10A	3.10e-05	2	194	2	18203008
Pubmed	TRAIL induces apoptosis but not necroptosis in colorectal and pancreatic cancer cells preferentially via the TRAIL-R2/DR5 receptor.	TNFRSF10B TNFRSF10A	3.10e-05	2	194	2	29278689
Pubmed	Plexin-B1/RhoGEF-mediated RhoA activation involves the receptor tyrosine kinase ErbB-2.	ERBB2 PLXNB1	3.10e-05	2	194	2	15210733
Pubmed	TRAIL-receptor expression is an independent prognostic factor for survival in patients with a primary glioblastoma multiforme.	TNFRSF10B TNFRSF10A	3.10e-05	2	194	2	16544055
Pubmed	Expression of tumor necrosis factor-related apoptosis-inducing ligand death receptors DR4 and DR5 in human nonmelanoma skin cancer.	TNFRSF10B TNFRSF10A	3.10e-05	2	194	2	24212133
Pubmed	MAP2K1 and MAP3K1 mutations in Langerhans cell histiocytosis.	MAP3K1 MAP2K1	3.10e-05	2	194	2	25899310
Pubmed	Characterization of 8p21.3 chromosomal deletions in B-cell lymphoma: TRAIL-R1 and TRAIL-R2 as candidate dosage-dependent tumor suppressor genes.	TNFRSF10B TNFRSF10A	3.10e-05	2	194	2	16051735
Pubmed	Plumbagin enhances TRAIL-mediated apoptosis through up-regulation of death receptor in human melanoma A375 cells.	TNFRSF10B TNFRSF10A	3.10e-05	2	194	2	20714870
Pubmed	HER2 phosphorylates and destabilizes pro-apoptotic PUMA, leading to antagonized apoptosis in cancer cells.	ERBB2 BBC3	3.10e-05	2	194	2	24236056
Pubmed	Mcl-1 confers protection of Her2-positive breast cancer cells to hypoxia: therapeutic implications.	ERBB2 MCL1	3.10e-05	2	194	2	26921175
Pubmed	CD4+CD25+ regulatory T cells suppress allograft rejection mediated by memory CD8+ T cells via a CD30-dependent mechanism.	MAP3K14 TNFRSF8	3.10e-05	2	194	2	14722622
Pubmed	MEK kinase 1 is a negative regulator of virus-specific CD8(+) T cells.	MAP3K1 MAP2K1	3.10e-05	2	194	2	16761309
Pubmed	Antagonism between MCL-1 and PUMA governs stem/progenitor cell survival during hematopoietic recovery from stress.	MCL1 BBC3	3.10e-05	2	194	2	25847014
Pubmed	Real-time imaging of the dynamics of death receptors and therapeutics that overcome TRAIL resistance in tumors.	TNFRSF10B TNFRSF10A	3.10e-05	2	194	2	22824792
Pubmed	ErbB-2 signals through Plexin-B1 to promote breast cancer metastasis.	ERBB2 PLXNB1	3.10e-05	2	194	2	22378040
Pubmed	Loss of MCL1 function sensitizes the MDA-MB-231 breast cancer cells to rh-TRAIL by increasing DR4 levels.	MCL1 TNFRSF10A	3.10e-05	2	194	2	30912136
Pubmed	The MAPK signaling cascade.	MAPK4 MAP2K1	3.10e-05	2	194	2	7601337
Pubmed	Heterodimerization of alpha 2A- and beta 1-adrenergic receptors.	ADRA2A ADRB1	3.10e-05	2	194	2	12529373
Pubmed	TRAIL receptor mediates inflammatory cytokine release in an NF-kappaB-dependent manner.	TNFRSF10B TNFRSF10A	3.10e-05	2	194	2	19434100
Pubmed	Secretory stressors induce intracellular death receptor accumulation to control apoptosis.	TNFRSF10B TNFRSF10A	3.10e-05	2	194	2	28981087
Pubmed	Novel domains in the hnRNP G/RBMX protein with distinct roles in RNA binding and targeting nascent transcripts.	RBMXL2 RBMX	3.10e-05	2	194	2	21327109
Pubmed	[Associations of Crohn's disease with DR4 and DR5 gene polymorphisms].	TNFRSF10B TNFRSF10A	3.10e-05	2	194	2	26418999
Pubmed	Efficacy of triple therapies including ionising radiation, agonistic TRAIL antibodies and cisplatin.	TNFRSF10B TNFRSF10A	3.10e-05	2	194	2	19424623
Pubmed	Tumor-derived mutations in the TRAIL receptor DR5 inhibit TRAIL signaling through the DR4 receptor by competing for ligand binding.	TNFRSF10B TNFRSF10A	3.10e-05	2	194	2	17666396
Pubmed	Replication of recently described type 2 diabetes gene variants in a South Indian population.	AHI1-DT WFS1 STK32C	4.69e-05	13	194	3	20580033
Pubmed	Combinatorial CRISPR-Cas9 screens for de novo mapping of genetic interactions.	ERBB2 MAP3K1 WEE1 MAP2K1 CDK4	4.95e-05	71	194	5	28319113
Pubmed	Transcriptome characterization elucidates signaling networks that control human ES cell growth and differentiation.	ERBB2 TNFRSF10A REPIN1 ZNF785 TNRC18 MGAT1 FGF2 MARVELD3 B4GALNT3 C6orf141 ZCCHC18 COL4A6 TOR2A FAM117B ZNF428 RPUSD1 SCAP USP54 CEP170B	5.51e-05	1215	194	19	15146197
Pubmed	Systematic bromodomain protein screens identify homologous recombination and R-loop suppression pathways involved in genome integrity.	ERBB2 ZNF219 TPRN TNFRSF10B REPIN1 PSMG3-AS1 GJD4 LARP4B ZNF469 MBD2 SAMD1 WEE1 FBRSL1 MAP7D1 MEPCE USP54 TOPORS CEP170B	5.89e-05	1116	194	18	31753913
Pubmed	An inducible CRISPR/Cas9 screen identifies DTX2 as a transcriptional regulator of human telomerase.	ERBB2 RBM12B ARHGEF11 PRR12 RBMX NOTCH3 LSR	7.22e-05	180	194	7	35198878
Pubmed	The thiazide-sensitive Na(+)-Cl(-) cotransporter gene, C1784T, and adrenergic receptor-beta3 gene, T727C, may be gene polymorphisms susceptible to the antihypertensive effect of thiazide diuretics.	ADRA1B ADRA2A ADRB1	9.07e-05	16	194	3	15824464
Pubmed	The p53 upregulated modulator of apoptosis (PUMA) chemosensitizes intrinsically resistant ovarian cancer cells to cisplatin by lowering the threshold set by Bcl-x(L) and Mcl-1.	MCL1 BBC3	9.25e-05	3	194	2	21863213
Pubmed	Down-regulation of Cbl-b by bufalin results in up-regulation of DR4/DR5 and sensitization of TRAIL-induced apoptosis in breast cancer cells.	TNFRSF10B TNFRSF10A	9.25e-05	3	194	2	22447040
Pubmed	Pharmacogenomic evaluation of the antidepressant citalopram in the mouse tail suspension test.	ADRA2A ADRB1	9.25e-05	3	194	2	16554742
Pubmed	Redistribution of CD95, DR4 and DR5 in rafts accounts for the synergistic toxicity of resveratrol and death receptor ligands in colon carcinoma cells.	TNFRSF10B TNFRSF10A	9.25e-05	3	194	2	15480430
Pubmed	Adenovirus RIDbeta subunit contains a tyrosine residue that is critical for RID-mediated receptor internalization and inhibition of Fas- and TRAIL-induced apoptosis.	TNFRSF10B TNFRSF10A	9.25e-05	3	194	2	12388693
Pubmed	[Effect of tumor necrosis factor-related apoptosis-inducing ligand on developing human oligodendrocytes in culture].	TNFRSF10B TNFRSF10A	9.25e-05	3	194	2	25845236
Pubmed	Ethanol inhibition of a T-type Ca²+ channel through activity of protein kinase C.	CACNA1I CACNA1H	9.25e-05	3	194	2	23488970
Pubmed	c-Cbl-mediated degradation of TRAIL receptors is responsible for the development of the early phase of TRAIL resistance.	TNFRSF10B TNFRSF10A	9.25e-05	3	194	2	19932172
Pubmed	The Effects of HER2 on CDK4/6 Activity in Breast Cancer.	ERBB2 CDK4	9.25e-05	3	194	2	34607757
Pubmed	Mitogen-activated protein kinase/extracellular signal-regulated kinase signaling in activated T cells abrogates TRAIL-induced apoptosis upstream of the mitochondrial amplification loop and caspase-8.	TNFRSF10B TNFRSF10A	9.25e-05	3	194	2	12218097
Pubmed	RBMX is a novel hepatic transcriptional regulator of SREBP-1c gene response to high-fructose diet.	RBMXL1 RBMX	9.25e-05	3	194	2	17188681
Pubmed	Involvement of tumor necrosis factor-related apoptosis-inducing ligand and tumor necrosis factor-related apoptosis-inducing ligand receptors in viral hepatic diseases.	TNFRSF10B TNFRSF10A	9.25e-05	3	194	2	16226105
Pubmed	Clinical significance and expression of PUMA, MCL-1, and p53 in human renal cell carcinoma and para-carcinoma tissues.	MCL1 BBC3	9.25e-05	3	194	2	28692117
Pubmed	The TRAIL system is over-expressed in breast cancer and FLIP a marker of good prognosis.	TNFRSF10B TNFRSF10A	9.25e-05	3	194	2	25230899
Pubmed	LARP4B is an AU-rich sequence associated factor that promotes mRNA accumulation and translation.	LARP4B LARP1	9.25e-05	3	194	2	26001795
Pubmed	Alpha-tocopheryl succinate induces DR4 and DR5 expression by a p53-dependent route: implication for sensitisation of resistant cancer cells to TRAIL apoptosis.	TNFRSF10B TNFRSF10A	9.25e-05	3	194	2	16529749
Pubmed	The expression of TRAIL and its receptors in gastric cancer and the apoptotic effect of rh-TRAIL on SGC7901 cells.	TNFRSF10B TNFRSF10A	9.25e-05	3	194	2	19212626
Pubmed	FLIP overexpression inhibits death receptor-induced apoptosis in malignant mesothelial cells.	TNFRSF10B TNFRSF10A	9.25e-05	3	194	2	15334061
Pubmed	Identification of the t-type calcium channel (Ca(v)3.1d) in developing mouse heart.	CACNA1I CACNA1H	9.25e-05	3	194	2	11230107
Pubmed	Interaction of plexin-B1 with PDZ domain-containing Rho guanine nucleotide exchange factors.	ARHGEF11 PLXNB1	9.25e-05	3	194	2	12220504
Pubmed	Homeostatic plasticity and burst activity are mediated by hyperpolarization-activated cation currents and T-type calcium channels in neuronal cultures.	CACNA1I CACNA1H	9.25e-05	3	194	2	33547341
Pubmed	Death receptor 5 is activated by fucosylation in colon cancer cells.	TNFRSF10B TNFRSF10A	9.25e-05	3	194	2	30589515
Pubmed	Calmodulin regulates Cav3 T-type channels at their gating brake.	CACNA1I CACNA1H	9.25e-05	3	194	2	28972185
Pubmed	RBMY evolved on the Y chromosome from a ubiquitously transcribed X-Y identical gene.	RBMXL1 RBMX	9.25e-05	3	194	2	10391207
Pubmed	Activated Cdc42-associated kinase 1 (Ack1) is required for tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) receptor recruitment to lipid rafts and induction of cell death.	TNFRSF10B TNFRSF10A	9.25e-05	3	194	2	24085293
Pubmed	Expression of TRAIL and the death receptors DR4 and DR5 correlates with progression of degeneration in human intervertebral disks.	TNFRSF10B TNFRSF10A	9.25e-05	3	194	2	19305384
Pubmed	Noxa induces apoptosis in oncogene-expressing cells through catch-and-release mechanism operating between Puma and Mcl-1.	MCL1 BBC3	9.25e-05	3	194	2	21945433
Interaction	TOP3B interactions	ERBB2 SETD1B KMT2B MORN1 TRIO TOR4A ARHGEF11 REPIN1 REXO1 PRR12 LARP4B TNRC18 MGAT1 HEG1 KCNH2 CASKIN1 TP53I13 CACNA1H MARVELD3 ZNF598 PRRC2A RBM15 SEMA7A SZT2 FBRSL1 SMG5 GRIN2D STK32C TESK1 GAS2L1 SCAP DNAJC14 KANK3 LRP3 MAPKBP1 LSM14B CABIN1 CEP170B	6.43e-09	1470	187	38	int:TOP3B
Interaction	ZNF683 interactions	PRR20C PRR20D PRR20B PRR20E PRR20A	1.58e-08	10	187	5	int:ZNF683
Interaction	CELF4 interactions	PRR20C PRR20D PRR20B PRR20E PRR20A	2.88e-08	11	187	5	int:CELF4
Interaction	ZCCHC14 interactions	PRR20C PRR20D MYO15B PRR20B PRR20E PRR20A USP54	4.31e-08	37	187	7	int:ZCCHC14
Interaction	BEND2 interactions	PRR20C PRR20D PRR20B PRR20E PRR20A	4.90e-08	12	187	5	int:BEND2
Interaction	TBX6 interactions	KLHDC7B PRR20C PRR20D PRR20B PRR20E PRR20A USP54	9.11e-08	41	187	7	int:TBX6
Interaction	PTTG2 interactions	PRR20C PRR20D PRR20B PRR20E PRR20A	1.22e-07	14	187	5	int:PTTG2
Interaction	MBNL3 interactions	PRR20C PRR20D PRR20B PRR20E PRR20A	2.62e-07	16	187	5	int:MBNL3
Interaction	PRR34 interactions	PRR20C PRR20D PRR20B PRR20E PRR20A	1.18e-06	21	187	5	int:PRR34
Interaction	TPRX1 interactions	PRR20C PRR20D PRR20B PRR20E PRR20A	1.18e-06	21	187	5	int:TPRX1
Interaction	MAPRE3 interactions	TRIO APC2 KLHDC7B LARP4B TTBK1 ZNF598 PRRC2A GAS2L1 MAP7D1 GAS2L2 PROSER2 CEP170B	1.69e-06	230	187	12	int:MAPRE3
Interaction	BICRAL interactions	QRICH1 PRR20C PRR20D PRR20B PRR20E PRR20A	2.70e-06	43	187	6	int:BICRAL
Interaction	C3orf36 interactions	PRR20C PRR20D PRR20B PRR20E PRR20A	3.66e-06	26	187	5	int:C3orf36
Interaction	PNMA2 interactions	ZNF785 MTCL1 TTLL10 PRRC2A FAM117B SAPCD2 ZNF783 MAP7D1 MCM9 HASPIN USP54 CEP170B	4.16e-06	251	187	12	int:PNMA2
Interaction	RBPMS2 interactions	KLHDC7B PRR20C PRR20D PRR20B PRR20E PRR20A USP54	1.21e-05	83	187	7	int:RBPMS2
Interaction	ZNF385C interactions	PRR20C PRR20D PRR20B PRR20E PRR20A	1.25e-05	33	187	5	int:ZNF385C
Interaction	BHLHE40 interactions	NUMBL KLHDC7B PRR20C PRR20D PRR20B PRR20E PRR20A USP54	1.54e-05	119	187	8	int:BHLHE40
Interaction	ZBTB32 interactions	PRR20C PRR20D MYO15B PRR20B PRR20E PRR20A	1.60e-05	58	187	6	int:ZBTB32
Interaction	FAM9A interactions	PRR20C PRR20D PRR20B PRR20E PRR20A TXLNA	1.76e-05	59	187	6	int:FAM9A
Interaction	CABP2 interactions	ZNF785 PRR20C PRR20D PRR20B PRR20E PRR20A	2.14e-05	61	187	6	int:CABP2
Interaction	HLX interactions	PRR20C PRR20D PRR20B PRR20E PRR20A	2.23e-05	37	187	5	int:HLX
Interaction	HSP90AA5P interactions	CDK11A RPS6KA4 DONSON MAP3K14 STK32C MEPCE CDK4	2.56e-05	93	187	7	int:HSP90AA5P
Interaction	CDC37 interactions	ERBB2 TRIO CDK11A GCH1 MAP3K1 PRR20C PRR20D PRR20B PRR20E RPS6KA4 MAP3K14 PRR20A STK32C TXLNA MAPK4 MAP3K21 MAP2K1 CDK4	3.35e-05	645	187	18	int:CDC37
Interaction	SMAP1 interactions	QRICH1 PRR20C PRR20D PRR20B PRR20E PRR20A	3.67e-05	67	187	6	int:SMAP1
Interaction	FAM222B interactions	PRR20C PRR20D PRR20B PRR20E PRR20A	4.20e-05	42	187	5	int:FAM222B
Interaction	TBX3 interactions	PRR20C PRR20D PRR20B PRR20E RBMX PRR20A	4.35e-05	69	187	6	int:TBX3
Interaction	SAMD11 interactions	PRR20C PRR20D PRR20B PRR20E PRR20A	4.71e-05	43	187	5	int:SAMD11
Interaction	TRIM35 interactions	CDK11A PRR20C PRR20D PRR20B PRR20E SAMD1 PRR20A	4.95e-05	103	187	7	int:TRIM35
Interaction	GLIS2 interactions	ERBB2 PRR20C PRR20D PRR20B PRR20E PRR20A CDK4	5.95e-05	106	187	7	int:GLIS2
Interaction	SP4 interactions	PRR20C PRR20D PRR20B PRR20E PRR20A	6.56e-05	46	187	5	int:SP4
Interaction	ARID5A interactions	QRICH1 PRR20C PRR20D PRR20B PRR20E KDF1 PRR20A IRX6	7.03e-05	147	187	8	int:ARID5A
Interaction	KRTAP19-1 interactions	PRR20C PRR20D PRR20B PRR20E PRR20A	7.29e-05	47	187	5	int:KRTAP19-1
Interaction	POU6F2 interactions	QRICH1 PRR20C PRR20D MYO15B PRR20B PRR20E KDF1 PRR20A	7.37e-05	148	187	8	int:POU6F2
Interaction	ESRP1 interactions	KLHDC7B PRR20C PRR20D PRR20B PRR20E PRR20A	8.09e-05	77	187	6	int:ESRP1
Interaction	OXER1 interactions	PRR20C PRR20D PRR20B PRR20E PRR20A	9.85e-05	50	187	5	int:OXER1
Interaction	PRR35 interactions	PRR20C PRR20D PRR20B PRR20E PRR20A USP54	1.23e-04	83	187	6	int:PRR35
Interaction	RIPPLY1 interactions	PRR20C PRR20D PRR20B PRR20E PRR20A	1.56e-04	55	187	5	int:RIPPLY1
Interaction	DMRT3 interactions	PRR20C PRR20D PRR20B PRR20E PRR20A USP54	1.60e-04	87	187	6	int:DMRT3
Interaction	PRR20B interactions	PRR20C PRR20D PRR20B PRR20E NOTCH3 PRR20A	1.92e-04	90	187	6	int:PRR20B
Interaction	PRR20C interactions	PRR20C PRR20D PRR20B PRR20E NOTCH3 PRR20A	1.92e-04	90	187	6	int:PRR20C
Interaction	PRR20D interactions	PRR20C PRR20D PRR20B PRR20E NOTCH3 PRR20A	1.92e-04	90	187	6	int:PRR20D
Interaction	PHF1 interactions	PRR20C PRR20D PRR20B PRR20E MBD2 PRR20A PROSER2 USP54	2.09e-04	172	187	8	int:PHF1
Interaction	ROR2 interactions	ERBB2 NUMBL PRR20C PRR20D PRR20B PRR20E PRR20A LSR C1orf198 B3GAT1 GAA	2.92e-04	333	187	11	int:ROR2
Cytoband	13q21.1	PRR20C PRR20D PRR20B PRR20E PRR20A	1.60e-09	13	194	5	13q21.1
Cytoband	Ensembl 112 genes in cytogenetic band chr13q21	PRR20C PRR20D PRR20B PRR20E PRR20A	1.46e-04	117	194	5	chr13q21
GeneFamily	Adrenoceptors	ADRA1B ADRA2A ADRB1	1.89e-05	9	112	3	169
GeneFamily	Mitogen-activated protein kinase kinase kinases\|RAF family	MAP3K1 MAP3K14 MAP3K21	4.26e-04	24	112	3	654
GeneFamily	CD molecules\|Tumor necrosis factor receptor superfamily\|Death inducing signaling complex	TNFRSF10B TNFRSF10A TNFRSF8	7.52e-04	29	112	3	782
GeneFamily	La ribonucleoprotein domain containing\|RNA binding motif containing	LARP4B LARP1	7.83e-04	7	112	2	625
GeneFamily	RNA binding motif containing	SETD1B RBMXL1 RBM12B RBMXL2 RBMX RBM15	2.12e-03	213	112	6	725
Coexpression	MEISSNER_NPC_HCP_WITH_H3K4ME2	BCORL1 SIDT1 EMILIN2 C2CD4C ERFE ADRA1B FGF2 LRRC75A NENF PEAR1 IRX6 GRIN2D YBX2 LSR TMEM238 CEP170B	6.91e-07	493	190	16	M1951
Coexpression	MEISSNER_NPC_HCP_WITH_H3K4ME2	BCORL1 SIDT1 EMILIN2 C2CD4C ERFE ADRA1B FGF2 LRRC75A NENF PEAR1 IRX6 GRIN2D YBX2 LSR TMEM238 CEP170B	9.23e-07	504	190	16	MM830
Coexpression	HE_LIM_SUN_FETAL_LUNG_C1_SMG_CELL	NUMBL SERTAD4-AS1 ARHGEF11 RTN2 PSMG3-AS1 RASSF5 MYO15B ZNF598 KIF13B RPS6KA4 SZT2 MYO18A C17orf58 GXYLT2 TMEM238 PAX1 TTC9 PROSER2 FBXO27	4.00e-06	775	190	19	M45713
Coexpression	MEISSNER_NPC_HCP_WITH_H3K4ME3_AND_H3K27ME3	GCH1 RASSF5 ADRA2A NEUROG1 B4GALNT3 CAMKK1 KHDRBS2 STK32C	1.01e-05	143	190	8	M1935
Coexpression	MEISSNER_NPC_HCP_WITH_H3K4ME3_AND_H3K27ME3	GCH1 RASSF5 ADRA2A NEUROG1 B4GALNT3 CAMKK1 KHDRBS2 STK32C	1.01e-05	143	190	8	MM819
Coexpression	MEISSNER_BRAIN_HCP_WITH_H3K4ME3_AND_H3K27ME3	ERBB2 SIDT1 EMILIN2 GCH1 TNFRSF10B C2CD4C ADRA1B ADRA2A KCNC3 KCNH2 SORCS2 ADAMTS17 MARVELD3 C6orf141 PEAR1 SMC4 SAPCD2 GXYLT2 WNT10A PAPPA MAP3K21	3.73e-05	1074	190	21	M1941
Coexpression	GINESTIER_BREAST_CANCER_ZNF217_AMPLIFIED_DN	ARHGEF11 REXO1 SLC12A9 ZNF598 PRRC2A SZT2 FBRSL1 LARP1 SMG5 LRCH4 LSM14B	3.90e-05	338	190	11	M17094
ToppCell	PCW_05-06-Epithelial-Epithelial_proliferating-epi_proliferating1_(8)\|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung	MARVELD3 C6orf141 KDF1 PRR36 SAPCD2 YBX2 LSR TMEM238 MAP3K21	1.68e-07	194	191	9	20f81f457ab0a404600effe8beb91fe73d1cfc10
ToppCell	Control-Epithelial_alveolar-AT_2-Differentiating_AT1\|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	REPIN1 REXO1 PRR12 ZSCAN1 MAP3K14 SCAP PROSER2 USP54	4.06e-07	157	191	8	4766f7d545bf2d775390589460677519cb92f4d5
ToppCell	renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_principal_cell-Cortical_Collecting_Duct_Principal_Cell\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	KCNC3 NPAP1 SORCS2 B4GALNT3 COL4A6 PAPPA CADPS2 MAP3K21	1.14e-06	180	191	8	023ec0b080c8a5cd0f36e83c6b17d4be3c01edb5
ToppCell	LPS-antiTNF-Epithelial_alveolar-Mes-Like-AT2\|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	CASKIN1 DNASE1L2 COL4A6 IRX6 GAS2L2 TMEM238 MAP3K21	1.16e-06	125	191	7	5626eb77e542fcc87cd1fdf65f8623f3249ff9db
ToppCell	E16.5-Epithelial-Epithelial_Alveolar-Epithelial_Alveolar-AT1-AT1_prolif\|E16.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	ARHGEF11 REPIN1 MTCL1 KDF1 LRRC75A SAMD1 YBX2 USP54	1.19e-06	181	191	8	f6629fa71bb94405f523f63a9264cacf6d15c5f4
ToppCell	AT1-AT2_cells-Donor_02\|World / lung cells shred on cell class, cell subclass, sample id	ERBB2 HEG1 WFS1 KHDRBS2 PTPN21 C1orf198 USP54 MAPK4	1.29e-06	183	191	8	6821dca076318115d360ff426eb1218cfe104063
ToppCell	kidney_cells-Hypertensive_with+without-CKD-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_principal_cell\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	ERBB2 KCNC3 NPAP1 SORCS2 COL4A6 PAPPA CADPS2 MAP3K21	1.85e-06	192	191	8	9e031bf93eb8757fdd0cc22f01b44e48f85532d5
ToppCell	TCGA-Thryoid-Primary_Tumor\|TCGA-Thryoid / Sample_Type by Project: Shred V9	FJX1 TNFRSF10B MANEAL LRRC75A SAMD1 PRR36 B3GAT1 CEP170B	2.08e-06	195	191	8	7cdee2ae90edf15e4cbcf70797b8caf1f037b0ef
ToppCell	TCGA-Thryoid-Primary_Tumor-Thyroid_Papillary_Carcinoma\|TCGA-Thryoid / Sample_Type by Project: Shred V9	FJX1 TNFRSF10B MANEAL LRRC75A SAMD1 PRR36 B3GAT1 CEP170B	2.08e-06	195	191	8	b61b8c931bd0ca3678486653ae1d7e9915c696c7
ToppCell	kidney_cells-Renal_AKI_(acute_kidney_injury)-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_principal_cell-Cortical_Collecting_Duct_Principal_Cell\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	KCNC3 NPAP1 COL4A6 IRX6 PAPPA CADPS2 MAP3K21	6.00e-06	160	191	7	7064af50fc10e3ea03badf415306222b74db0f95
ToppCell	TCGA-Ovary-Primary_Tumor-Ovarian_Carcinoma-Serous_Cystadenocarcinoma-5\|TCGA-Ovary / Sample_Type by Project: Shred V9	SETD1B RBM12B PLXNB1 SZT2 DNAJC14 MEPCE MAP3K21	7.64e-06	166	191	7	32d2eaf8a5d03881bf74d680825af2d5110b082d
ToppCell	TCGA-Uvea-Primary_Tumor-Uveal_Melanoma-Spindle_Cell-1\|TCGA-Uvea / Sample_Type by Project: Shred V9	PEAR1 RPS6KA4 GAS2L1 KANK3 LRP3 CABIN1 RTN4RL2	8.26e-06	168	191	7	b427746929bb40e3d1b5f1c40d302b792d6b32a5
ToppCell	AT1-AT2_cells-Cryobiopsy_01\|World / lung cells shred on cell class, cell subclass, sample id	ERBB2 ASCL5 CACNA1H MTCL1 WFS1 PTPN21 LSR	9.63e-06	172	191	7	0be41df5d35d818deb7316ac21c9366eb4b7bfd1
ToppCell	AT1-AT2_cells-SSc-ILD_01\|World / lung cells shred on cell class, cell subclass, sample id	GJD4 CACNA1H NOTCH3 CYP27C1 LRCH4 WNT10A PAPPA	1.29e-05	180	191	7	3c7b2033821f9e34e2924bd8655f566edcbcc7d3
ToppCell	facs-Lung-EPCAM-3m-Mesenchymal-Myofibroblast\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	KCNH2 PLXNB1 NOTCH3 CABP1 COL4A6 C1orf198 PAPPA	1.29e-05	180	191	7	d67d3196e6cc3dcd31023a4dc69310226181d583
ToppCell	facs-Lung-EPCAM-3m-Mesenchymal-pulmonary_interstitial_fibroblast\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	KCNH2 PLXNB1 NOTCH3 CABP1 COL4A6 C1orf198 PAPPA	1.29e-05	180	191	7	573308d43425d9fba20787abdb7f8efefc48efb5
ToppCell	renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_principal_cell-Outer_Medullary_Collecting_Duct_Principal_Cell\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	NPAP1 SORCS2 COL4A6 FAM117B PAPPA CADPS2 MAP3K21	1.44e-05	183	191	7	b5ede5a0048c585b73c00e88aeddbcaf669347b1
ToppCell	3'-GW_trimst-1.5-SmallIntestine-Epithelial-neuro-epithelial-EECs\|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	ZSCAN1 CACNA1H FBXO33 C6orf141 PLXNB1 KIF13B MYO18A	1.55e-05	185	191	7	d42f6722a6771752cd744146a09e2ead9b7252bc
ToppCell	droplet-Lung-LUNG-1m-Epithelial-Club_Cell\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	REPIN1 KCNC3 KCNH2 KDF1 PLXNB1 TTC9 PROSER2	1.60e-05	186	191	7	e52cf44989c57c433bf82e9fa13b4643e88f3577
ToppCell	droplet-Lung-LUNG-1m-Epithelial-club_cell_of_bronchiole\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	REPIN1 KCNC3 KCNH2 KDF1 PLXNB1 TTC9 PROSER2	1.60e-05	186	191	7	4c0b59d845b79323e7a3287e7c4d249f5f322556
ToppCell	renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_principal_cell-Outer_Medullary_Collecting_Duct_Principal_Cell\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	KCNC3 NPAP1 SORCS2 COL4A6 PAPPA CADPS2 MAP3K21	1.66e-05	187	191	7	e3095455d2f255854f339f6b05fa87852af0700f
ToppCell	renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_principal_cell\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	KCNC3 NPAP1 SORCS2 COL4A6 PAPPA CADPS2 MAP3K21	1.77e-05	189	191	7	3a295c215b5c18e7c673f92b7af5be523421682c
ToppCell	renal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_principal_cell\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	KCNC3 NPAP1 SORCS2 COL4A6 PAPPA CADPS2 MAP3K21	1.83e-05	190	191	7	11d3c31167ea71809b4cc3757a0c6ea54a448602
ToppCell	kidney_cells-Hypertensive_with+without-CKD-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_principal_cell-Cortical_Collecting_Duct_Principal_Cell\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	ERBB2 KCNC3 NPAP1 IRX6 PAPPA CADPS2 MAP3K21	1.83e-05	190	191	7	078f4be52fa4cc8dd9c8d7a2b6d9631c3d902285
ToppCell	renal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_principal_cell-Degenerative_Outer_Medullary_Collecting_Duct_Principal_Cell\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	ERBB2 NPAP1 SORCS2 COL4A6 PAPPA CADPS2 MAP3K21	1.90e-05	191	191	7	0a0719a0a49ae0099d61e22585ac74c10c24b4a2
ToppCell	renal_cortex_nuclei-Adult_normal_reference-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_principal_cell\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	NPAP1 SORCS2 COL4A6 PAPPA MAPK4 CADPS2 MAP3K21	1.96e-05	192	191	7	fd08ae787e936cfdb1ab8f19b0fd63005b462709
ToppCell	kidney_cells-Hypertensive_with+without-CKD-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_principal_cell-Degenerative_Outer_Medullary_Collecting_Duct_Principal_Cell\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	ERBB2 NPAP1 SORCS2 COL4A6 PAPPA CADPS2 MAP3K21	1.96e-05	192	191	7	3d777d07878269b87ec7e1f06489cae7c989d633
ToppCell	renal_cortex_nuclei-Adult_normal_reference-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_principal_cell-Cortical_Collecting_Duct_Principal_Cell\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	NPAP1 SORCS2 COL4A6 PAPPA MAPK4 CADPS2 MAP3K21	1.96e-05	192	191	7	bae236c9f1fac77bce28d0a9cf090100d391ff77
ToppCell	kidney_cells-Adult_normal_reference-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_principal_cell\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	ERBB2 KCNC3 NPAP1 SORCS2 IRX6 PAPPA CADPS2	2.03e-05	193	191	7	371f4c98a599923fbe8382530b3eab05d873665a
ToppCell	facs-Brain_Non-Myeloid-Hippocampus-3m-Endothelial-Endothelial_cell\|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation	MCL1 GCH1 HEG1 SEMA7A LSR KANK3 PROSER2	2.03e-05	193	191	7	e4b440d50ae7391b26924778be6d9d53e0692449
ToppCell	facs-Brain_Non-Myeloid-Hippocampus-3m-Endothelial\|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation	MCL1 GCH1 HEG1 SEMA7A LSR KANK3 PROSER2	2.03e-05	193	191	7	e523dc5751f6fdcd4fc1a62b1eecd43f6ae79da9
ToppCell	facs-Brain_Non-Myeloid-Hippocampus-3m-Endothelial-endothelial_cell\|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation	MCL1 GCH1 HEG1 SEMA7A LSR KANK3 PROSER2	2.03e-05	193	191	7	1772f2ac217727de63c4a9303881b3a19a6bb0f0
ToppCell	renal_cortex_nuclei-Adult_normal_reference-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_principal_cell-Degenerative_Outer_Medullary_Collecting_Duct_Principal_Cell\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	ERBB2 NPAP1 SORCS2 COL4A6 PAPPA CADPS2 MAP3K21	2.10e-05	194	191	7	d602a0cdb69cd5a3e9ef61ddbab8d920557dd73e
ToppCell	distal-1-Hematologic-Plasmacytoid_Dendritic\|1 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed)	BCORL1 SIDT1 FAM30A ZNF469 RPS6KA4 SEMA7A WNT10A	2.31e-05	197	191	7	166d47359df9279ea8c3946f10bd3d4b88c95857
ToppCell	LPS_anti-TNF-Epithelial_alveolar-AT_1-Differentiating_AT2\|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type	SORCS2 MTCL1 PLXNB1 LSR USP54 CADPS2 MAP3K21	2.31e-05	197	191	7	3d13a4f2e86422900ee2194e8a1fd1cf9750d5d3
ToppCell	TCGA-Adrenal-Primary_Tumor-Pheochromocytoma-Pheochromocytoma-5\|TCGA-Adrenal / Sample_Type by Project: Shred V9	CARMIL3 TPBGL TTBK1 MTCL1 PLXNB1 KIAA1614	2.47e-05	134	191	6	d4b175257c47916ed90cdb5c555c2b26530ce8d5
ToppCell	Biopsy_Other_PF-Epithelial-KRT5-/KRT17+\|Biopsy_Other_PF / Sample group, Lineage and Cell type	B4GALNT3 PLXNB1 NOTCH3 CYP27C1 LSR WNT10A PAPPA	2.55e-05	200	191	7	077e6b9340686de9d0f11b035a8954e1f6a1b790
ToppCell	LPS_only-Epithelial_alveolar-AT_1-Differentiating_AT1\|LPS_only / Treatment groups by lineage, cell group, cell type	ERBB2 MTCL1 PLXNB1 LSR USP54 CADPS2 CEP170B	2.55e-05	200	191	7	2dadf317a42a7e27cc1fac74f91b806c93a57108
ToppCell	Fetal_brain-organoid_Tanaka_cellReport-GW16-Neuronal-Intermediate\|GW16 / Sample Type, Dataset, Time_group, and Cell type.	EIF4E3 COL4A6 WEE1 ZNF783 B3GAT1 TMEM238 MAP2K1	2.55e-05	200	191	7	a3fcd901cb281920f1bafdfd676399a6dc37355e
ToppCell	E16.5-samps-Mesenchymal-Matrix_fibroblast-_fetal-Mature_Fibroblast_2\|E16.5-samps / Age Group, Lineage, Cell class and subclass	TPRN ADRA1B EXOC3L4 KIF13B WFS1 PAX1	2.92e-05	138	191	6	05de2cef97c0912fb23f138dd45348f565a14d74
ToppCell	AT1-AT2_cells-Donor_04\|World / lung cells shred on cell class, cell subclass, sample id	TPRN APC2 WFS1 KHDRBS2 PTPN21 TMEM238	3.17e-05	140	191	6	45d52a086ced8d58e01ac51ac4a90338e8649b16
ToppCell	renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_principal_cell-Cortical_Collecting_Duct_Principal_Cell\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	KCNC3 NPAP1 SORCS2 COL4A6 PAPPA CADPS2	4.16e-05	147	191	6	64fa0753a3a79f492ef8acc6942bf90d379a983f
ToppCell	LPS-antiTNF-Stromal_mesenchymal-Fibroblasts-Monocytes-Macrophages\|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	EMILIN2 MANEAL KDF1 LRRC75A KHDRBS2 RPUSD1	4.84e-05	151	191	6	f13a117ae26ae525da4f3e837d8f204d00dc6ee3
ToppCell	renal_papilla_nuclei-Adult_normal_reference-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_principal_cell-Cortical_Collecting_Duct_Principal_Cell\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	SORCS2 MTCL1 PLXNB1 SAPCD2 OTOP1 PAPPA	4.84e-05	151	191	6	f4f7156b2c0cfc78fd1841e07c9915d97ced561f
ToppCell	renal_papilla_nuclei-Adult_normal_reference-Epithelial-Collecting_tubule_epithelial_cell-kidney_connecting_tubule_epithelial_cell\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	KLHDC7B PRR20B SORCS2 MTCL1 MAPK4 CADPS2	5.02e-05	152	191	6	eee86b508b8f140ea44e21d8c04c409a7b689e39
ToppCell	Healthy_donor-B_cell\|Healthy_donor / disease group, cell group and cell class (v2)	FAM30A ZNF785 KDF1 PLXNB1 SLX1A MAP3K21	5.02e-05	152	191	6	5768edfde8010324d8594815e73bbfba2c3045f3
ToppCell	Striatum-Neuronal-Inhibitory\|Striatum / BrainAtlas - Mouse McCarroll V32	SIDT1 RASSF5 ADRA1B KCNH2 ADAMTS17 GRIN2D	6.01e-05	157	191	6	c41ff3fe9de7187575114febfe9bd8733366fb8a
ToppCell	367C-Epithelial_cells-Epithelial-B_(AT2)\|Epithelial_cells / Donor, Lineage, Cell class and subclass (all cells)	ST20-AS1 ADAMTS17 ZCCHC18 DONSON SMC4	6.15e-05	97	191	5	eab10b1af9cd0ce373cd4d0316e0d7b218630584
ToppCell	367C-Epithelial_cells-Epithelial-B_(AT2)-\|Epithelial_cells / Donor, Lineage, Cell class and subclass (all cells)	ST20-AS1 ADAMTS17 ZCCHC18 DONSON SMC4	6.15e-05	97	191	5	04f571708f2487b0dbd70ee507de6bf75be5f5d9
ToppCell	droplet-Liver-Hepatocytes-18m-Myeloid-nan\|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	RBM12B ARHGEF11 MAGI2 LSM11 EIF4E3	6.45e-05	98	191	5	95162072f3afc95e46f29db3d79ebd930bc09726
ToppCell	Smart-start-Cell-Wel_seq-Neoplastic-Stem-like-NPC-like-NPC-like_neural-A\|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group	CARMIL3 PRR36 CYP27C1 ZNF428 PLEKHA6 YBX2	6.91e-05	161	191	6	bd520c9a1927d5d5355b4421e6b90b58bfb76a42
ToppCell	renal_medulla_nuclei-Adult_normal_reference-Epithelial-Collecting_tubule_epithelial_cell-kidney_connecting_tubule_epithelial_cell-Connecting_Tubule_Principal_Cell\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	NPAP1 COL4A6 PAPPA MAPK4 CADPS2 MAP3K21	7.15e-05	162	191	6	285e6d553f485fd9f1075c4e1b940da251b5ea35
ToppCell	Healthy_Control-Lymphoid-Plasma\|Healthy_Control / Condition, Lineage, Cell class and cell subclass	KLHDC7B FAM30A MYO15B SEMA7A MYO18A CBFA2T3	7.39e-05	163	191	6	2913ccdd4613472cd82077d4993e1d9f8b223398
ToppCell	Healthy_Control-Lymphoid-Plasma-\|Healthy_Control / Condition, Lineage, Cell class and cell subclass	KLHDC7B FAM30A MYO15B SEMA7A MYO18A CBFA2T3	7.39e-05	163	191	6	b589ff57d58dcb215ee3b5a10d81f43e5752a196
ToppCell	368C-Myeloid-Dendritic-cDC1\|Dendritic / Donor, Lineage, Cell class and subclass (all cells)	NOTCH3 SEMA7A ARHGAP39 CBFA2T3 GXYLT2 FBXO27	7.39e-05	163	191	6	299ac2463b7f58eee419d822a2a2d64b973d87e9
ToppCell	356C-Myeloid-Dendritic-pDC\|Myeloid / Donor, Lineage, Cell class and subclass (all cells)	SIDT1 FAM30A MTCL1 PLXNB1 RPS6KA4 CBFA2T3	7.65e-05	164	191	6	fed26f4ac36a2b0722bc7b9f91659c5e0cf4d53a
ToppCell	droplet-Liver-Npc-18m-Lymphocytic-B_cell\|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	SORCS2 CACNA1I CACNA1H TTLL10 BEND5 WNT10A	8.73e-05	168	191	6	ce9fae8b295c668b0959d5007a8bcd401d80e258
ToppCell	PND10-Immune-Immune_Myeloid-DC-cDC2-cDC2_G2M\|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	RBM12B ADRA2A MAP3K14 SMC4 MCM9 HASPIN	8.73e-05	168	191	6	4c402a1613fcf0a6e4d9b9d5551812940e91ff32
ToppCell	(3)_MNP-(3)_DC_plasmacytoid\|(3)_MNP / Lung cell shreds - cell class (v4) and cell subclass (v4)	SIDT1 FAM30A MTCL1 SEMA7A CBFA2T3 WNT10A	8.73e-05	168	191	6	13c160ea1a19b47d2e7e2dae818c8dcde4e3e377
ToppCell	356C-Myeloid-Dendritic-cDC_activated\|Myeloid / Donor, Lineage, Cell class and subclass (all cells)	REPIN1 EXOC3L4 ZCCHC18 SEMA7A MAP3K14 FBXO27	9.02e-05	169	191	6	44d201361eb497222a4972a0e10bac1e05dcfd0a
ToppCell	droplet-Liver-Npc-18m-Lymphocytic-B_cell\|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	SORCS2 CACNA1I CACNA1H TTLL10 BEND5 WNT10A	9.63e-05	171	191	6	584a095ddcbf78aa29527f84b46b5ad3e2edbaa9
ToppCell	facs-Skin-Skin_Anagen-18m-Epithelial-epidermal_cell\|Skin / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation	NOTCH3 WEE1 GAS2L1 LSR TTC9 BBC3	1.03e-04	173	191	6	0f9c1d3298e59e6d22bb3306f0f445f490be8bbd
ToppCell	wk_15-18-Hematologic-Myeloid-pDC\|wk_15-18 / Celltypes from embryonic and fetal-stage human lung	SIDT1 FAM30A RPS6KA4 SEMA7A CBFA2T3 WNT10A	1.03e-04	173	191	6	b571970e3ba88afc07041c5692ccfd85fc39e796
ToppCell	droplet-Limb_Muscle-MUSCLE-1m-Endothelial-unknown\|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	SLC12A9 CACNA1H ZNF428 LRP3 PROSER2 USP54	1.06e-04	174	191	6	c58328c2f262506a4518f49f148e29874faf9171
ToppCell	AT1-AT2_cells-HP_01\|World / lung cells shred on cell class, cell subclass, sample id	ADRB1 WFS1 KHDRBS2 C1orf198 LRCH4 MAPK4	1.09e-04	175	191	6	9a95ab5c361ebaa8747983c5a0d69025682a19ad
ToppCell	droplet-Trachea-3m-Mesenchymal-myofibroblast-tracheobronchial_smooth_muscle_cell-smooth_muscle_cell_of_trachea_l6-17\|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	ADRA2A KCNH2 NOTCH3 SEMA7A CBFA2T3 TNFRSF8	1.27e-04	180	191	6	455d1e3ccf2ab609954f3b870e8f514ddca735f4
ToppCell	Globus_pallidus-Neuronal-Inhibitory\|Globus_pallidus / BrainAtlas - Mouse McCarroll V32	RASSF5 ADRA1B KCNH2 LARP1 GRIN2D CEP170B	1.35e-04	182	191	6	04ccfa951eaa31fed6d140edb6c702d49363c5fa
ToppCell	kidney_cells-Adult_normal_reference-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_principal_cell-Cortical_Collecting_Duct_Principal_Cell\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	KCNC3 NPAP1 COL4A6 PAPPA CADPS2 MAP3K21	1.52e-04	186	191	6	aeac0c2db173cd1ea45b5052ab418d6cacd198d8
ToppCell	343B-Fibroblasts-Fibroblast-E-\|343B / Donor, Lineage, Cell class and subclass (all cells)	PRR12 SORCS2 PEAR1 FAM117B PTPN21 PAPPA	1.52e-04	186	191	6	1bac7825c2fe3e6cdff65026b09b9ccaa40fa27f
ToppCell	343B-Fibroblasts-Fibroblast-E\|343B / Donor, Lineage, Cell class and subclass (all cells)	PRR12 SORCS2 PEAR1 FAM117B PTPN21 PAPPA	1.52e-04	186	191	6	59db239f1864a5d4f1570c93219dbd7ac5b6db35
ToppCell	facs-Trachea-3m-Mesenchymal-myofibroblast-tracheobronchial_smooth_muscle_cell-smooth_muscle_cell_of_trachea_l20-23\|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	RTN2 ERFE NOTCH3 WNT10A TTC9 RTN4RL2	1.57e-04	187	191	6	69b47f00598d647e2a99427ebddf42c339428e47
ToppCell	TCGA-Prostate-Primary_Tumor-Prostate_Adenocarcinoma\|TCGA-Prostate / Sample_Type by Project: Shred V9	TPRN REPIN1 PRR36 TOR2A SAPCD2 TMEM238	1.57e-04	187	191	6	fa0452f3382c22c0391b241d06504fda3c6a19f0
ToppCell	Children_(3_yrs)-Epithelial-alveolar_epithelial_cell_type_1-D139\|Children_(3_yrs) / Lineage, Cell type, age group and donor	MTCL1 WFS1 KHDRBS2 PTPN21 C1orf198 MAPK4	1.57e-04	187	191	6	d4b0afd9b92c47c8aa348bbd1af7eb54c3d478f2
ToppCell	TCGA-Prostate-Primary_Tumor\|TCGA-Prostate / Sample_Type by Project: Shred V9	TPRN REPIN1 PRR36 TOR2A SAPCD2 TMEM238	1.57e-04	187	191	6	3e6a95c912dad5d61e10497ffaafd2b9027cd13a
ToppCell	TCGA-Colorectal-Primary_Tumor-Colorectal_Adenocarcinoma-Colon_Adenocarcinoma-7\|TCGA-Colorectal / Sample_Type by Project: Shred V9	TRIO ZNF469 NOTCH3 PPP1R3D LSM14B SPATA25	1.61e-04	188	191	6	14bc73cf79c79c9f208369fd8d498e5b26e0114d
ToppCell	TCGA-Breast-Primary_Tumor-Breast_Carcinoma-Infiltrating_Lobular_Carcinoma-6\|TCGA-Breast / Sample_Type by Project: Shred V9	SORCS2 PEAR1 KIF13B MAP3K14 GXYLT2 KANK3	1.61e-04	188	191	6	c90669b51e1902fe7726555290c91c92a911df83
ToppCell	Substantia_nigra-Neuronal-Inhibitory-iN1(Gad1Gad2_Th)\|Substantia_nigra / BrainAtlas - Mouse McCarroll V32	CARMIL3 RASSF5 PRR36 GRIN2D PAPPA GAA	1.61e-04	188	191	6	b73e8a40393c3f656e2fcfe395a761b1f985c254
ToppCell	renal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_principal_cell-Cortical_Collecting_Duct_Principal_Cell\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	NPAP1 SORCS2 COL4A6 PAPPA CADPS2 MAP3K21	1.61e-04	188	191	6	e30a4ddac0da8cdcf621d98e28e3895cd9307e7a
ToppCell	myeloid-pDC\|myeloid / Lineage and Cell class	SIDT1 FAM30A TP53I13 SEMA7A CBFA2T3 WNT10A	1.61e-04	188	191	6	a2dc4bbeca2bdc00c51825dd65a699c54c72f241
ToppCell	renal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial-Collecting_tubule_epithelial_cell\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	NPAP1 B4GALNT3 COL4A6 CADPS2 MAP3K21 HS6ST3	1.66e-04	189	191	6	a9864873b19ab3e60acf11f288fa7275badc2e42
ToppCell	renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_principal_cell\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	NPAP1 SORCS2 COL4A6 PAPPA CADPS2 MAP3K21	1.66e-04	189	191	6	bfc76a72b600d641c8fe58346e5d8986c34f3981
ToppCell	facs-Skin-Skin_Anagen-18m-Epithelial-Basal_IFE\|Skin / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation	MCL1 WEE1 WNT10A TTC9 PROSER2 MAPKBP1	1.66e-04	189	191	6	1cfc1fe27c4b57b4e52700fa8f679ce172cee5a9
ToppCell	15-Airway-Epithelial-Basal_cell\|Airway / Age, Tissue, Lineage and Cell class	C6orf141 KDF1 IRX6 LSR WNT10A PAX1	1.66e-04	189	191	6	f128c2fc37f232d193de18a922c47fdd70e1982d
ToppCell	5'-GW_trimst-1.5-LargeIntestine-Mesenchymal-Pericytes-Contractile_pericyte_(PLN+)\|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	ASCL5 FJX1 CACNA1H NOTCH3 CABP1 SPATA25	1.71e-04	190	191	6	a7f6c38bbf451f166febb21e6719d4afced4035e
ToppCell	renal_cortex_nuclei-Adult_normal_reference-Epithelial-Collecting_tubule_epithelial_cell\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	SORCS2 B4GALNT3 COL4A6 PAPPA CADPS2 HS6ST3	1.71e-04	190	191	6	b3bccf4dd95e986db3cee324a6737f5fcc22e8e5
ToppCell	Children_(3_yrs)-Epithelial-alveolar_epithelial_cell_type_1-D032\|Children_(3_yrs) / Lineage, Cell type, age group and donor	HEG1 KHDRBS2 PTPN21 C1orf198 USP54 MAPK4	1.71e-04	190	191	6	30b50d183d7649146eb1e79b47ba897355f1998a
ToppCell	wk_08-11-Epithelial-Airway_epithelial_progenitor-epi-stalk_early\|wk_08-11 / Celltypes from embryonic and fetal-stage human lung	GCH1 MARVELD3 C6orf141 PRR36 LSR MAP3K21	1.71e-04	190	191	6	9f5f65869dad9a43ac94f81f9a19c72ffe5adc3c
ToppCell	renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_principal_cell-Cortical_Collecting_Duct_Principal_Cell\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	NPAP1 SORCS2 COL4A6 PAPPA CADPS2 MAP3K21	1.71e-04	190	191	6	b7f8c2bb9459f1d7c1690069dd5a25a81a57cc84
ToppCell	(09)_Interm._secr.>cil.-(0)_Reference\|(09)_Interm._secr.>cil. / shred by cell type by condition	NUMBL GJD4 PRRC2A PLXNB1 DONSON KIAA1614	1.76e-04	191	191	6	e63432718d62d39165ba8a66e14bb38c93907ffe
ToppCell	facs-Brain_Non-Myeloid-Cortex-3m-Endothelial-Endothelial_cell\|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation	GCH1 HEG1 SEMA7A LSR KANK3 PROSER2	1.81e-04	192	191	6	9ae05db5bfb8b9d3935c0328e6f2d489d2b1ebfd
ToppCell	facs-Brain_Non-Myeloid-Cortex-3m-Endothelial\|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation	GCH1 HEG1 SEMA7A LSR KANK3 PROSER2	1.81e-04	192	191	6	a116db7dec495e5a0ba9c7537057cd1e567d7885
ToppCell	facs-Brain_Non-Myeloid-Cortex-3m-Endothelial-endothelial_cell\|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation	GCH1 HEG1 SEMA7A LSR KANK3 PROSER2	1.81e-04	192	191	6	66defad13bd8e79319741e43ddb056841710b1d7
ToppCell	distal-Hematologic-Basophil/Mast_2-3\|distal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed)	FAM30A ADRA2A KCNH2 MTCL1 SEMA7A FBXO27	1.86e-04	193	191	6	f22d0a2ea6bbdd625909ccb6a89aca89ab670306
ToppCell	distal-Hematologic-Basophil/Mast_2\|distal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed)	FAM30A ADRA2A KCNH2 MTCL1 SEMA7A FBXO27	1.86e-04	193	191	6	dcdc1498726c68bf590bf84cb81e5f7fb7ba4d78
ToppCell	distal-3-Hematologic-Basophil/Mast_2\|3 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed)	ADRA2A KCNH2 MTCL1 SEMA7A CBFA2T3 FBXO27	1.86e-04	193	191	6	23c6c798525dad43eff792727902ea562bf373be
ToppCell	COVID-19-kidney-CD-PC\|kidney / Disease (COVID-19 only), tissue and cell type	NPAP1 SORCS2 COL4A6 PAPPA CADPS2 MAP3K21	1.86e-04	193	191	6	738689d009e4b118d7ce3171a207294b95cbe78b
ToppCell	Smart-start-Cell-Wel_seq-Neoplastic-Differentiated-like-MES-like-MES-like_hypoxia_independent-G\|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group	FJX1 FGF2 C6orf141 COL4A6 WEE1 GXYLT2	1.91e-04	194	191	6	f44394c8a6f86483063f2f5722f003a8a0a70254
ToppCell	356C-Epithelial_cells-Epithelial-H_(AT1)-\|356C / Donor, Lineage, Cell class and subclass (all cells)	TOR4A RTN2 MAP3K14 PLEKHA6 DNAJC14 CADPS2	1.91e-04	194	191	6	4c40d6b50675eae52c419d69e719a9223df02ae3
ToppCell	356C-Epithelial_cells-Epithelial-H_(AT1)\|356C / Donor, Lineage, Cell class and subclass (all cells)	TOR4A RTN2 MAP3K14 PLEKHA6 DNAJC14 CADPS2	1.91e-04	194	191	6	99a90de637e3babec2131cdd9f05ea965d8a8f30
ToppCell	Monocytes-Inflammatory_CD16+_macrophages\|Monocytes / Immune cells in Kidney/Urine in Lupus Nephritis	GCH1 RASSF5 HEG1 MBD2 TNFRSF8 TTC9	1.91e-04	194	191	6	28d19105123b015f8aa25ea8e6c078f630d4ba80
Drug	Muramic acid, N-acetyl [10597-89-4]; Up 200; 13.6uM; MCF7; HT_HG-U133A	TRIO BCORL1 ARHGEF11 RTN2 CACNA1H PRRC2A NOTCH3 WIPF1 PTPN21 LSR SCAP	7.10e-07	193	190	11	3262_UP
Drug	Amiodarone	ADRB1 KCNH2 CACNA1H	2.27e-06	4	190	3	DB01118
Drug	trazodone	ADRA1B ADRA2A KCNH2 FGF2 CACNA1I CACNA1H	4.11e-06	51	190	6	CID000005533
Drug	Trichostatin A, from Streptomyces sp.; Down 200; 0.1uM; MCF7; HT_HG-U133A	FJX1 LARP1 SMG5 ZNF428 PTPN21 CBFA2T3 ZNF783 MCM9 MEPCE	1.11e-05	166	190	9	2268_DN
Drug	thymoxamine	ADRA1B ADRA2A ADRB1 TNFRSF8	1.31e-05	18	190	4	CID000004260
Drug	6,7-dimethoxy-2-(pyrrolidin-1-yl)-N-(5-(pyrrolidin-1-yl)pentyl)quinazolin-4-amine	APC2 BCORL1 TNFRSF10B PRR12 NOTCH3 PRR36 ZNF428	2.71e-05	104	190	7	ctd:C000595015
Drug	benoxathian	ADRA1B ADRA2A ADRB1 TNFRSF8	3.06e-05	22	190	4	CID000002325
Drug	silodosin	ADRA1B ADRA2A ADRB1 KCNH2	3.06e-05	22	190	4	CID005312125
Drug	Epinephrine	ADRA1B ADRA2A ADRB1	3.11e-05	8	190	3	DB00668
Drug	vemurafenib	MCL1 TNFRSF10B TNFRSF10A MAP2K1 BBC3 CDK4	3.61e-05	74	190	6	ctd:C551177
Drug	tizanidine	GCH1 ADRA1B ADRA2A ADRB1	3.67e-05	23	190	4	CID000005487
Drug	borane (2	MCL1 GCH1 TNFRSF10B TNFRSF10A BCL2L12 DNAJC14	3.90e-05	75	190	6	CID000139760
Drug	Palmatine chloride [3486-67-7]; Up 200; 10.4uM; MCF7; HT_HG-U133A	SIDT1 RTN2 HEG1 FGF2 KIF13B SMC4 PAPPA TTC9 CABIN1	3.99e-05	195	190	9	2795_UP
Drug	Glycocholic acid [475-31-0]; Up 200; 8.6uM; MCF7; HT_HG-U133A	ARHGEF11 CACNA1I CACNA1H MBD2 RPS6KA4 WIPF1 PRR36 PLEKHA6 LSM14B	4.15e-05	196	190	9	3315_UP
Drug	PHA-00767505E [723337-45-9]; Down 200; 10uM; PC3; HT_HG-U133A	ZNF219 PTDSS2 RTN2 SMG5 PLEKHA6 PTPN21 PPP1R3D LRP3 LSM14B	4.32e-05	197	190	9	6545_DN
Drug	dipivefrin	ADRA1B ADRA2A ADRB1	4.63e-05	9	190	3	CID000003105
Drug	Minocycline hydrochloride [13614-98-7]; Down 200; 8uM; MCF7; HT_HG-U133A	SETD1B KMT2B TRIO ARHGEF11 SLC12A9 MTCL1 PLXNB1 TTC9 CABIN1	4.67e-05	199	190	9	7436_DN
Disease	obsolete aging, cognition	PRR20C PRR20D PRR20B PRR20E PRR20A	2.35e-08	15	181	5	EFO_0003925, GO_0007568
Disease	mosaic loss of chromosome Y measurement	PRR20C PRR20D PRR20B PRR20E EIF4E3 PRR20A	1.01e-05	80	181	6	EFO_0007783
Disease	Tinnitus, wellbeing measurement	PRR20C PRR20D PRR20B PRR20E PRR20A PTPN21	2.88e-05	96	181	6	EFO_0007869, HP_0000360
Disease	PROSTATE CANCER, HEREDITARY, 1	LARP4B MBD2 FBRSL1 B3GAT1 MAP2K1	3.41e-05	60	181	5	C4722327
Disease	t-tau:beta-amyloid 1-42 ratio measurement	PRR20C PRR20D PRR20B PRR20E PRR20A	5.42e-05	66	181	5	EFO_0007708
Disease	Prostate cancer, familial	LARP4B MBD2 FBRSL1 B3GAT1 MAP2K1	6.72e-05	69	181	5	C2931456
Disease	prostate carcinoma	TRIO SIDT1 LINC00472 TNFRSF10B MAP3K1 EZHIP RASSF5 LARP4B ADRB1 MBD2 RBM15 FBRSL1 C17orf58 B3GAT1 MAP3K21 MAP2K1	1.30e-04	891	181	16	EFO_0001663
Disease	triglyceride measurement, coronary artery disease	SETD1B FBRSL1	2.23e-04	4	181	2	EFO_0001645, EFO_0004530
Disease	Schizophrenia	AHI1-DT NUMBL GCH1 ARHGEF11 MAGI2 ADRA2A NEUROG1 KCNH2 FGF2 MBD2 PLEKHA6 GRIN2D PTPN21 B3GAT1 CADPS2	3.80e-04	883	181	15	C0036341
Disease	hypertension	TTBK1 ADRB1 SLC12A9 SORCS2 SEMA7A SZT2 FBRSL1 FAM219B	6.48e-04	307	181	8	EFO_0000537
Disease	lysophosphatidylethanolamine 20:4 measurement	CACNA1I FBXO33 TNKS	7.38e-04	29	181	3	EFO_0010370
Disease	stanniocalcin-1 measurement	LARP4B B4GALNT3	1.02e-03	8	181	2	EFO_0020753
Disease	Ventricular Dysfunction	ADRB1 GAA	1.02e-03	8	181	2	C0242973
Disease	Malignant Neoplasms	ERBB2 TNFRSF10A KCNH2 MAP2K1 CDK4	1.18e-03	128	181	5	C0006826
Disease	renal cell carcinoma (is_marker_for)	ERBB2 TNFRSF10A FGF2 MAP2K1 CDK4	1.18e-03	128	181	5	DOID:4450 (is_marker_for)
Disease	urinary bladder cancer (is_implicated_in)	ERBB2 TNFRSF10A FGF2 CDK4	1.25e-03	76	181	4	DOID:11054 (is_implicated_in)
Disease	monocyte count	ST20-AS1 KLHDC7B MCL1 TNFRSF10B TNFRSF10A RASSF5 EIF4E3 NENF PEAR1 SZT2 MAP3K14 PLEKHA6 FAM219B KIAA1614 GXYLT2 MAPK4 CABIN1 BBC3	1.32e-03	1320	181	18	EFO_0005091
Disease	Cardiomegaly	ADRA1B ADRA2A FGF2 CABIN1	1.65e-03	82	181	4	C0018800
Disease	Cardiac Hypertrophy	ADRA1B ADRA2A FGF2 CABIN1	1.65e-03	82	181	4	C1383860
Disease	Parkinsonism (is_implicated_in)	GCH1 FGF2	1.98e-03	11	181	2	DOID:0080855 (is_implicated_in)
Disease	dystonia (implicated_via_orthology)	GCH1 TOR2A	2.37e-03	12	181	2	DOID:543 (implicated_via_orthology)
Disease	dystonia (is_implicated_in)	KMT2B GCH1	3.24e-03	14	181	2	DOID:543 (is_implicated_in)
Disease	telomere length	PRR20C PRR20D PRR20B PRR20E CACNA1H PRRC2A PRR20A	3.31e-03	313	181	7	EFO_0004505
Disease	total cholesterol measurement, triglyceride measurement, low density lipoprotein cholesterol measurement, high density lipoprotein cholesterol measurement	SETD1B ADRB1 FBRSL1	3.40e-03	49	181	3	EFO_0004530, EFO_0004574, EFO_0004611, EFO_0004612
Disease	pancreatic adenocarcinoma (is_implicated_in)	MAP2K1 CDK4	3.73e-03	15	181	2	DOID:4074 (is_implicated_in)
Disease	head and neck squamous cell carcinoma (is_implicated_in)	TNFRSF10B TNFRSF10A	3.73e-03	15	181	2	DOID:5520 (is_implicated_in)
Disease	Mood Disorders	ADRA1B ADRA2A ADRB1 FGF2 WFS1	3.86e-03	168	181	5	C0525045
Disease	lung non-small cell carcinoma (is_marker_for)	BCORL1 MCL1 RASSF5 BBC3 CDK4	3.96e-03	169	181	5	DOID:3908 (is_marker_for)
Disease	Squamous cell carcinoma of the head and neck	TNFRSF10B WEE1 CDK4	4.02e-03	52	181	3	C1168401
Disease	Abnormal behavior	BCORL1 PRR12	4.24e-03	16	181	2	C0233514
Disease	body mass index, osteoarthritis	CACNA1H SEMA7A CADPS2	4.48e-03	54	181	3	EFO_0004340, MONDO_0005178
Disease	Dystonia, Limb	KMT2B GCH1	4.79e-03	17	181	2	C0751093
Disease	Dystonia, Diurnal	KMT2B GCH1	4.79e-03	17	181	2	C0393610
Disease	autosomal dominant intellectual developmental disorder (is_implicated_in)	KMT2B TRIO	4.79e-03	17	181	2	DOID:0060307 (is_implicated_in)
Disease	Dystonia, Paroxysmal	KMT2B GCH1	5.37e-03	18	181	2	C0393588
Disease	breast cancer (is_marker_for)	KMT2B MAP3K1 FGF2 MAP2K1 CDK4	5.79e-03	185	181	5	DOID:1612 (is_marker_for)

Protein segments in the cluster

Peptide	Gene	Start	Entry
ELGAGPESPPRAPRD	BEND5	46	Q7L4P6
SDPRRETPPGADPRE	B3GAT1	41	Q9P2W7
CERRFLGGPARPPSP	ADRB1	261	P08588
PSPPDDGDFLRTPRR	EXOC3L4	226	Q17RC7
SPREGPLPAARPAGA	ERBB2	1151	P04626
GAPPRGAAPAPRTAR	FBRSL1	51	Q9HCM7
DRGNPGPVGIPSPRR	COL4A6	946	Q14031
APRRPQPAGARLPAG	CYP27C1	31	Q4G0S4
PATPRPDRPGDGEAR	ASCL5	236	Q7RTU5
GPRPRPAGDSPRKTQ	B4GALNT3	546	Q6L9W6
DVRDSGGRPLPPPDT	BBC3	236	Q96PG8
PGPRPSGARDRAPGA	FAM219B	16	Q5XKK7
TPAERPGGLDDRSPP	BCORL1	1741	Q5H9F3
QGGNDDPRRPSRSPP	ARHGEF11	1401	O15085
RRGEAAGSPVPTPPR	BCL2L12	106	Q9HB09
LPAPEPPGRRGRHDS	ADRA1B	456	P35368
RGPGRPSTPARAPAT	AHI1-DT	56	P0C7V0
RGPTPADRDRPSVPA	CEP170B	436	Q9Y4F5
RGRRSPRAPGEPTPA	CEP170B	781	Q9Y4F5
PAARGPEGQPAPEAR	CCNQ	11	Q8N1B3
SRREPRSLPAGGPAP	CABP1	26	Q9NZU7
RSLPAGGPAPRRTAP	CABP1	31	Q9NZU7
TRRAPPEPGPESGQA	C2CD4C	281	Q8TF44
RTPPAAPRARPGERA	ADAMTS17	66	Q8TE56
GDAAETPPRPRTPGR	MAP2K1	281	Q02750
AASGGPRRPERHLPP	NUMBL	6	Q9Y6R0
RPPGEDFRSPPDDFR	RBM12B	866	Q8IXT5
PPAAPTRPGSRARGN	RTN4RL2	311	Q86UN3
RAPDPLRGARDRTPP	RBM15	556	Q96T37
PPRAARGPTPRTEEA	TP53I13	296	Q8NBR0
GRDSYGGPPRREPLP	RBMX	186	P38159
ARGNLEPPPRASRPA	RASSF5	66	Q8WWW0
PPPSQQGSPREGERR	QRICH1	221	Q2TAL8
GYAPDGPPGVRSRRP	ARHGAP39	231	Q9C0H5
SAVEGAPPARPRPRS	IRX6	361	P78412
DVRGRSPPERPVPGT	MTCL1	301	Q9Y4B5
PPELSPGAGDRERAP	LRCH4	376	O75427
EGTPSSRGPRRDPPR	MORN1	6	Q5T089
GGRAARRPPEGHPTP	CASKIN1	1016	Q8WXD9
PGTRGRQRATPDAPP	DNAJC14	626	Q6Y2X3
GGEPDGSARRPRPPC	LARP1	46	Q6PKG0
AGAGSPARPPSPRLD	LSM11	11	P83369
VPAAPGPSGRTRRRP	LSM11	86	P83369
GPSGRTRRRPDAPAP	LSM11	91	P83369
GRPEAGRPASEARAP	MAGI2	1336	Q86UL8
PRPPGGAPARKAAVA	MAGI2	1416	Q86UL8
PALSLREGGPRAPRP	LYSMD2	6	Q8IV50
RDGRCPPRSSPGAPE	PSMG3-AS1	96	Q96PY0
ASGPPAPARRGAPNI	NEUROG1	41	Q92886
GEARLSDPPGRAAPP	MEPCE	96	Q7L2J0
RPAPGRPPSVSALDG	MGAT1	31	P26572
DEARPAGPGPAPASR	DYNLT4	36	Q5JR98
RRLSASPPGRPAPVD	MAPK4	516	P31152
EPTRNGVDPPPRARA	CAMKK1	36	Q8N5S9
AERASPGAAPGPRRE	LRRC75A	11	Q8NAA5
FGTEDRPTDRPAPPR	LSM14B	46	Q9BX40
REAARAPAGPPGPRL	C17orf58	91	Q2M2W7
ESAPGPARRGRASVP	EZHIP	261	Q86X51
PGPARRGRDSAPVSA	EZHIP	286	Q86X51
RRALVGPGSPPRSAP	KCNH2	231	Q12809
RRGHPAPPAPGSERR	KIAA1614	521	Q5VZ46
PRDQRRPAGGRPSPS	LARP4B	706	Q92615
DRRRPPDPTGTSEPG	CARMIL3	1356	Q8ND23
LGPRRCPDPREPASG	GJD4	106	Q96KN9
SVPQPRPPGARTRAG	FBXO33	6	Q7Z6M2
DRCLVGPRAPAPRDP	C1orf198	71	Q9H425
DEPEPPRPRRGSLRG	PLXNB1	1891	O43157
GPGIPRPGHRSRAPE	MYO18A	181	Q92614
RREPPPGPLDRGSSR	PEAR1	871	Q5VY43
EPGAPSRSRARREPP	ERFE	31	Q4G0M1
PRGPGESRAGPAARP	ERFE	51	Q4G0M1
RAGRAEPPALPARPA	GXYLT2	26	A0PJZ3
PSPGSEPRARRELAP	NOTCH3	1561	Q9UM47
AGQTPRPAERGPPVR	NENF	31	Q9UMX5
RAAGDRPPSAPGRAP	LRP3	661	O75074
VGDPDFPAPPRRSRR	KMT2B	1901	Q9UMN6
SRRGSPAPANPGRAP	RPS6KA4	741	O75676
ERRGPATPGPSYRAP	HEG1	71	Q9ULI3
DPRAGRPPRPAAGPA	PAPPA	31	Q13219
APRGPRKGGPAPVDR	CBFA2T3	41	O75081
QREGSSPRPGPAIPR	FAM170B	41	A6NMN3
AGPPAVPGPARRAQA	HS6ST3	46	Q8IZP7
AAAPPAGAREPPGSR	EIF4E3	6	Q8N5X7
RAREPRPGLAQDPPG	PTPN21	731	Q16825
PESPPPAERGRRRGG	PRR20D	66	P86480
ASEGVLPRPPGRSAP	MYO15B	71	Q96JP2
PESPPPAERGRRRGG	PRR20A	66	P86496
PESPPPAERGRRRGG	PRR20B	66	P86481
PPEDRLPRRPARSGG	FJX1	41	Q86VR8
APRREPVPFPSGSAG	MBD2	121	Q9UBB5
REGSLPAPAARPRTP	PAX1	426	P15863
PRSPESPAPRRGGVR	OTOP1	36	Q7RTM1
PARPAPSRGRGAPSL	LINC00472	26	Q9H8W2
PQGASPRRGRPALPA	APC2	2021	O95996
SAPPSPPAGRRRRGA	IGF2-AS	131	Q6U949
PGRPARDRGPESRPT	CABIN1	1781	Q9Y6J0
APGTGERAPPLPSRR	DNASE1L2	136	Q92874
EPGAPGLRRAPPRTR	DOCK8-AS1	76	Q5T8R8
SGRRVAPPRDAADPP	C6orf141	141	Q5SZD1
DVSLPRGAFPPRGPR	CDK4	241	P11802
SPRPASPVPGSERRG	GAS2L1	301	Q99501
PTPSSPRPRRERGAG	GAS2L2	336	Q8NHY3
TRSAAPGARGSPPRP	FAM117B	126	Q6P1L5
PAPGPRAGLSPAARR	CACNA1I	2051	Q9P0X4
GRSGDPRPQAAEPPD	CEP170P1	91	Q96L14
RAPPAPTREGRRDAP	CADPS2	31	Q86UW7
RSPPRPPRERFELGD	CDK11A	221	Q9UQ88
SRPGPRDAQAHPGRP	GAA	61	P10253
PDDPDFPGSPVRRRR	HASPIN	66	Q8TF76
KGDPGRRRPESEPPS	MARVELD3	146	Q96A59
PFERRPEGAPAPAAR	MANEAL	46	Q5VSG8
AGGSPAPVRRRPEAS	MAP7D1	396	Q3KQU3
LDPAPAANPGPRRRG	MAPKBP1	841	O60336
RPRVAAEPPDGPARE	DONSON	86	Q9NYP3
APRAAPAARGSRPGP	FGF2	116	P09038
ERGPAARRAPGPPTS	KANK3	56	Q6NY19
RSGLPRGPRGEEPPA	KLHDC7B	296	Q96G42
RGPRGEEPPAAAPVS	KLHDC7B	301	Q96G42
PPVARGVPTPRARGA	KHDRBS2	236	Q5VWX1
PSGPATAEDPGRRPV	EMILIN2	811	Q9BXX0
PERGARRSSPDAPGL	FAM30A	96	Q9NZY2
SRGRAARVPAPEPEP	FBXO27	6	Q8NI29
PRRPGPEPGACDTRL	CACNA1H	536	O95180
ALPRGDRPGRAPPAA	SAMD1	296	Q6SPF0
DRPGRAPPAASARPS	SAMD1	301	Q6SPF0
EEPGDSPPLRHRPRG	SCAP	846	Q12770
PDSRRVARPPPIGAE	MCL1	71	Q07820
DPSRPGPPSGRVERA	LSR	416	Q86X29
RELSPRAPGPRPAEE	MAP3K14	691	Q99558
RAPGPRPAEETTGRA	MAP3K14	696	Q99558
SGRITPPRRAPSPDG	MAP3K1	281	Q13233
PERKNRGERGPSSPP	MCM9	1076	Q9NXL9
GRERPDLEAPAPGSP	KIF13B	1631	Q9NQT8
DPEDRGPRPGSPSAL	RPUSD1	261	Q9UJJ7
PGRRGDPDTAPPSER	RTN2	121	O75298
PETSGPPDGQRRHRP	SZT2	2866	Q5T011
SGKGRPDRPARRPSP	REXO1	446	Q8N1G1
GRDSYGGPPRREPLP	RBMXL1	186	Q96E39
HGRAPPRRSGALPPA	TOR2A	206	Q8N2E6
PPRGRSEAPDSLNGP	SMG5	541	Q9UPR3
GSPRLRERPAPVGPG	SERTAD4-AS1	16	Q5TG53
NAAPDPRAPGPRRAR	MAP3K21	216	Q5TCX8
RTPAARGPRSGDPGP	PROSER2	226	Q86WR7
ASRPPASGRGERAPP	PRR36	91	Q9H6K5
ARCSNGFPERDPPRP	GCH1	16	P30793
PESPPPAERGRRRGG	PRR20C	66	P86479
RRDAGGPRPESPVPA	PTDSS2	6	Q9BVG9
GPRPESPVPAGRASL	PTDSS2	11	Q9BVG9
RVPRSPPAGRAEPGG	SORCS2	66	Q96PQ0
PDGPSRFPRVAGPRG	PRRC2A	276	P48634
ERTGPPPREGPSRRA	PRRC2A	2126	P48634
PPREGPSRRAEEPGS	PRRC2A	2131	P48634
PESPPPAERGRRRGG	PRR20E	66	P86478
PGRGAAASDRRSPVP	SLC35E2A	211	P0CK97
GARDSGEFRRAPAPP	SETD1B	421	Q9UPS6
PRPQGDSARAPPLRA	RNF217	31	Q8TC41
PSPDRAPPSRRDGQR	KDF1	136	Q8NAX2
DFCPPNPGPDGPRRR	PRR12	1141	Q9ULL5
GRGAPAPLSRDASPP	NPAP1	21	Q9NZP6
GRDGYSGPPRREPLP	RBMXL2	186	O75526
SRAPDLGGPSRPRPL	SPATA25	111	Q9BR10
PRGRPAVTAPRPGGD	REPIN1	216	Q9BWE0
PPPAAGQPRARDSGD	STK32C	36	Q86UX6
PDAVAAPPGGTERRP	ADRA2A	251	P08913
APPAPARKGRQAPGR	APOL5	416	Q9BWW9
GGPSRRAPRAAQPPA	ZNF428	76	Q96B54
DPRPCERAPRGPAGP	TNRC18	471	O15417
RGVPPPEDLRSPSRF	PLEKHA6	326	Q9Y2H5
QGPADGSRPEPQRPR	YBX2	306	Q9Y2T7
RSPTEPGPERRRSPG	WEE1	66	P30291
GPRPRRRESDPTGPQ	TTBK1	646	Q5TCY1
GPRDPTRAPARPGDQ	SAPCD2	101	Q86UD0
SARARPRVPAESGPG	ST20-AS1	76	Q8NBB2
QPPAPRRDPFDAARG	SIDT1	31	Q9NXL6
PEGDGSRDPPDRPRS	TNKS	66	O95271
VPPRDGAQGPVAPRS	ZSCAN1	361	Q8NBB4
PRDIRLTPRPGPNGS	SLC12A9	216	Q9BXP2
AGGPSSPRDLPEPRV	TNFRSF8	491	P28908
LEPRACRPPGSPGRA	PPP1R3D	36	O95685
ARRREEGPPPPSPDG	SMC4	11	Q9NTJ3
PGRAAPSAPRARVPG	SEMA7A	6	O75326
SGSNRRERGAPPLPP	WIPF1	486	O43516
VARGGPSATLPRPDP	TESK1	336	Q15569
GPREARGARPGPRVP	TNFRSF10B	21	O14763
GRAPGPRPAREASPR	TNFRSF10A	71	O00220
PPRERQGPGDRSPSP	nan	166	Q6ZRN7
APGSRADPAPRVPRA	ZNF469	1001	Q96JG9
RGPEDPRGPRRSPRT	ZNF598	381	Q86UK7
GAPRPGCSPRAPRAD	TOR4A	56	Q9NXH8
DPPAAPRRRGSPERA	TPRN	141	Q4KMQ1
GEAPPPAPASEGRRR	TOPORS	16	Q9NS56
PTGAPPFRGRARPLD	ZCCHC18	291	P0CG32
PRRAPAPAAPAGSRA	TPBGL	361	P0DKB5
PAPRRRAGPFDDAEP	SLX1A	161	Q9BQ83
GRTPRPFTPGLADPR	URB1-AS1	36	Q96HZ7
RRAARAPPPPAAGSR	TMEM238	141	C9JI98
APGAPGPRRRASPAD	WNT10A	321	Q9GZT5
RPRPPGPDLDSAHDG	TTLL10	621	Q6ZVT0
LRAPGPASGPARAPQ	ZNF219	331	Q9P2Y4
GPSAPSRRPPGADAE	TRIO	2386	O75962
APRPAHVPGEAGPRR	ZNF785	6	A8K8V0
PERRPEGPGAQAPSS	TXLNA	501	P40222
LPPPGERERDSRPAS	TTC9	91	Q92623
PRVRAGEPRPPGASG	ZNF783	321	Q6ZMS7
DPVPGSRTPGPRRVD	USP54	1621	Q70EL1
ERSERPRAPGPQAGP	WFS1	36	O76024
PAPRGPGDRRAEPCP	KCNC3	56	Q14003
PGDRRAEPCPGLPAA	KCNC3	61	Q14003
RAAPRGAAGRPLSPP	GRIN2D	981	O15399